ReeNT is a biotechnology company that develops ENT medical solutions and regenerative medicines for the healthcare industry.
ReeNT has raised $3.8M in total funding. The most recent round was Corporate Round. The last funding was announced in May 2026.
ReeNT's investors include Mitsubishi UFJ Capital, Nissay Capital, Alfresa Holdings.
ReeNT is headquartered in Tokyo, Japan.
ReeNT is a biotechnology company that develops ENT medical solutions and regenerative medicines for the healthcare industry.
ReeNT is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ReeNT — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/reent. Accessed September 30, 2026.
VCBacked. (2026). ReeNT — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/reent
{{cite web |title=ReeNT — Funding & Investors |url=https://www.vcbacked.co/company/reent |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated